Conditionally Immortalized Human Adipose Tissue-Derived Mesenchymal Stem Cells

CIHA001 Primary Cells
$5,800.00
Starting price per unit
Conditionally Immortalized Human Adipose Tissue-Derived Mesenchymal Stem Cells
In Stock 1ml
Product Type Stem Cells
Viability >80% viable (Trypan Blue exclusion)
Storage Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
Shelf Life Very stable in the Liquid Nitrogen Vapor Phase

Quick Actions

Quality Certified
Global Shipping Available
Technical Support Included
Product Data Sheet
Technical Documentation

Download detailed specifications, protocols, and safety information

File size: 156.2 KB

Product Overview

Description

Conditionally Immortalized Human Adipose Tissue-derived mesenchymal stem cells (hAT-MSCs) are a specialized category of adult stem cells isolated from human adipose (fat) tissue and engineered for extended or indefinite proliferative capacity under controlled conditions. Unlike permanently immortalized tumor-derived cell lines, conditionally immortalized cells retain the ability to revert to a non-proliferating, differentiation-competent state, making them particularly valuable for both research and therapeutic applications.

IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.

Key Features

Catalog Number: CIHA001
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:2 (P2)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)

Quick Facts
Product Type

Stem Cells

Viability

>80% viable (Trypan Blue exclusion)

Applications

1. Regenerative Medicine: Due to their ability to…

Availability

In Stock • Global Shipping

Technical Specifications

Product Type
Stem Cells
Viability
>80% viable (Trypan Blue exclusion)
Storage Conditions
Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
Shelf Life
Very stable in the Liquid Nitrogen Vapor Phase
Product Code
CIHA001
Size/Format
1ml
Primary Applications
1. Regenerative Medicine: Due to their ability to secrete large amounts of angiogenic factors (VEGF HGF FGF EGF IGF) and immunomodulatory cytokines (IL-6 IL-8) these cells are being evaluated for wound healing tissue repair and vascularization therapies. 2. Cartilage and Bone Engineering: Modified lines (e.g. SOX9-overexpressing ASC52telo) have demonstrated enhanced chondrogenic potential and responsiveness to mechanical and inflammatory stimuli providing platforms for studying joint disease and drug screening. 3. In Vitro Disease Modeling: Standardized immortalized lines reduce donor-to-donor variability and cell heterogeneity that complicate primary cell studies enabling reproducible experimental models. 4. Cell Tracking: Fluorescently labeled immortalized hAT-MSCs can be employed in in vivo cell-tracking experiments expanding their utility in preclinical studies. 5. Conditioned Medium Therapy: The secretome of these cells rich in growth factors and cytokines can be harvested as conditioned medium offering a cell-free alternative to direct transplantation with reduced risks associated with heterologous cell therapy.

Applications & Use Cases

Primary Applications
1. Regenerative Medicine: Due to their ability to secrete large amounts of angiogenic factors (VEGF

Suitable for 1. regenerative medicine: due to their ability to secrete large amounts of angiogenic factors (vegf studies and research applications

HGF

Suitable for hgf studies and research applications

FGF

Suitable for fgf studies and research applications

EGF

Suitable for egf studies and research applications

IGF) and immunomodulatory cytokines (IL-6

Suitable for igf) and immunomodulatory cytokines (il-6 studies and research applications

IL-8)

Suitable for il-8) studies and research applications

these cells are being evaluated for wound healing

Suitable for these cells are being evaluated for wound healing studies and research applications

tissue repair

Suitable for tissue repair studies and research applications

and vascularization therapies. 2. Cartilage and Bone Engineering: Modified lines (e.g.

Suitable for and vascularization therapies. 2. cartilage and bone engineering: modified lines (e.g. studies and research applications

SOX9-overexpressing ASC52telo) have demonstrated enhanced chondrogenic potential and responsiveness to mechanical and inflammatory stimuli

Suitable for sox9-overexpressing asc52telo) have demonstrated enhanced chondrogenic potential and responsiveness to mechanical and inflammatory stimuli studies and research applications

providing platforms for studying joint disease and drug screening. 3. In Vitro Disease Modeling: Standardized immortalized lines reduce donor-to-donor variability and cell heterogeneity that complicate primary cell studies

Suitable for providing platforms for studying joint disease and drug screening. 3. in vitro disease modeling: standardized immortalized lines reduce donor-to-donor variability and cell heterogeneity that complicate primary cell studies studies and research applications

enabling reproducible experimental models. 4. Cell Tracking: Fluorescently labeled immortalized hAT-MSCs can be employed in in vivo cell-tracking experiments

Suitable for enabling reproducible experimental models. 4. cell tracking: fluorescently labeled immortalized hat-mscs can be employed in in vivo cell-tracking experiments studies and research applications

expanding their utility in preclinical studies. 5. Conditioned Medium Therapy: The secretome of these cells rich in growth factors and cytokines

Suitable for expanding their utility in preclinical studies. 5. conditioned medium therapy: the secretome of these cells rich in growth factors and cytokines studies and research applications

can be harvested as conditioned medium

Suitable for can be harvested as conditioned medium studies and research applications

offering a cell-free alternative to direct transplantation with reduced risks associated with heterologous cell therapy.

Suitable for offering a cell-free alternative to direct transplantation with reduced risks associated with heterologous cell therapy. studies and research applications

Research Areas
In Vitro Studies

Cell culture and screening applications

Molecular Biology

Gene expression & signaling studies

Drug Discovery

Screening & validation studies

Disease Modeling

Pathophysiology research

Support & Resources

Technical Support

Our experts are available for technical questions and protocol assistance.

Contact Support
Documentation

Access product datasheets, protocols, and certificates.

Request Documentation
Shipping & Logistics

Temperature-controlled shipping to 40+ countries worldwide.

Shipping Info
FAQ & Resources

Find answers to common questions and optimization tips.

View FAQs